Jones S C, Alavi A, Christman D, Montanez I, Wolf A P, Reivich M
J Nucl Med. 1982 Jul;23(7):613-7.
Bladder and brain time-activity measurements in humans were performed after the intravenous administration of 2-[F-18]fluoro-2-deoxy-D-glucose. Radiation doses were calculated using the MIRD schema. The bladder wall received an average of 440 mrad/mCi (s.e. 76) in ten subjects who voided at 2 hr after administration of tracer. If these subjects had voided at 1 hr, the bladder-wall dose would have been reduced to 220 mrad/mCi. The brain received an average of 81 mrad/mCi in eight subjects. The doses to other organs, calculated from published dog biodistribution data, are between 50 and 85 mrad/mCi except for spleen and heart, which both received 160 mrad/mCi. These time-activity measurements for the critical organ in the human avoid the assumptions made in using animal biodistribution data for human dosimetry calculations.
在静脉注射2-[F-18]氟-2-脱氧-D-葡萄糖后,对人体进行膀胱和脑的时间-活度测量。使用MIRD模式计算辐射剂量。在注射示踪剂后2小时排尿的10名受试者中,膀胱壁平均接受440毫拉德/毫居里(标准误76)。如果这些受试者在1小时排尿,膀胱壁剂量将降至220毫拉德/毫居里。8名受试者的脑平均接受81毫拉德/毫居里。根据已发表的犬生物分布数据计算,除脾脏和心脏均接受160毫拉德/毫居里外,其他器官的剂量在50至85毫拉德/毫居里之间。人体关键器官的这些时间-活度测量避免了在使用动物生物分布数据进行人体剂量学计算时所做的假设。